Tentt

Servier Going-Private Day One Biopharmaceuticals Tender

Announced
HealthcareGoing Private

Deal Overview

Servier Detroit Inc., a wholly owned subsidiary of Servier Pharmaceuticals LLC and an indirect wholly owned subsidiary of Servier S.A.S., filed Amendment No. 2 to its Schedule TO for a going-private tender offer for all outstanding shares of Day One Biopharmaceuticals, Inc. The filing relates to the offer for Day One common stock (par value $0.0001 per share; CUSIP 23954D109).

The amendment updates Item 11 Additional Information, including revised language in the Offer to Purchase section on antitrust compliance under the HSR Act. The Schedule TO was originally filed March 26, 2026.

Key Details

Transaction
Servier acquires Day One Biopharmaceuticals

Filed under

Source

Read full article on sec.gov

via SEC EDGAR — SC TO · April 8, 2026

Powered by Tentt

Source healthcare deals for your firm

Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.

Book a 30-min intro call

Related Deals

See all Healthcare deals →